Not available
Quote | BeiGene Ltd. (NASDAQ:BGNE)
Last: | $143.93 |
---|---|
Change Percent: | 1.28% |
Open: | $143.04 |
Close: | $143.93 |
High: | $145.69 |
Low: | $142.8 |
Volume: | 243,547 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | BeiGene Ltd. (NASDAQ:BGNE)
2024-06-21 14:41:10 ET Summary Brukinsa, a BTK inhibitor by BeiGene, shows strong revenue growth amidst ongoing patent litigation with AbbVie. BeiGene's financial health appears stable, with a favorable current ratio and a cash runway extending into 2026. I recommend buying Be...
2024-06-19 12:30:39 ET Summary In recent months, Eli Lilly has continued to delight investors with growth in its share price. Strong sales of the company's diabetes franchise, coupled with progress in the development of tirzepatide, have helped its market capitalization double ove...
Message Board Posts | BeiGene Ltd. (NASDAQ:BGNE)
Subject | By | Source | When |
---|---|---|---|
BGNE having a nice bounce and a good, | MiamiGent | investorshub | 07/05/2023 7:28:03 PM |
Thoughts on where this is headed? | StockLearner2011 | investorshub | 07/03/2023 9:49:33 PM |
Found an interesting article | luke424 | investorshub | 06/30/2023 1:45:08 AM |
$BGNE must see | StockLearner2011 | investorshub | 06/28/2023 1:49:55 AM |
here we go bulls news is here | StockLearner2011 | investorshub | 06/22/2023 3:12:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Arm D of SEQUOIA study evaluated treatment-naïve patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma with del(17p) and/or TP53 mutation Preliminary data suggest promising efficacy and tolerability Safety profile was consistent with results o...
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with BeiGene’s goals to expand its presence and directly manage operations in the MENA region. T...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 with a fireside chat at 1:20 pm EDT. Live webcast of this event can be acce...